Short bowel condition Withdrawn Phase 3 Trials for Morphine (DB00295)

Also known as: Short-bowel syndrome / Short Bowel Syndrome / Congenital volvulus

IndicationStatusPhase
DBCOND0020575 (Short bowel condition)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02242656A Phase III Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Investigational Product MP-101 in Subjects With Short Bowel Syndrome Who Have Had an Inadequate Response to Anti-DiarrhealsTreatment
NCT02246816A Open Label Extension Study for Subjects That Complete Study MP-101-CL-001Treatment